We produced in BaciUus subtilis the complete, as well as the N-terminal two-thirds, OmpA protein of Escherichia coli (called here Bac-OmpA and Bac-OmpA-dN, respectively). These Bac-OmpA proteins were used to examine the immunological properties of different parts of OmpA, free of lipopolysaccharide and other components of the outer membrane. The full-length Bac-OmpA was indistinguishable from the authentic protein isolated from E. col (Coli-OmpA) both as immunogen and as antigen in enzyme immunoassay (EIA). The N-terminal Bac-OmpA-dN was a poor immunogen which gave rise to significantly lower titers of antiOmpA antibody than did the full-length OmpA preparations. When used as an antigen in EIA, the Bac-OmpAdN detected anti-OmpA antibody in serum samples from animals immunized with the full-length OmpA much less efficiently than did either Bac-OmpA or Coli-OmpA. The periplasmic C-terminal domain therefore appears to be an immunodominant epitope of the purified OmpA protein. Also, when rabbits and mice were immunized with intact, live or dead E. coli, the antibody response detected by EIA with the full-length protein, Bac-OmpA, was much stronger than that detected with the N-terminal two-thirds, Bac-OmpA-dN. Similar results were obtained with the OmpA of Salmonella typhimurium. Because the ompA gene of enterobacteria is highly conserved, the Bac-OmpA might be useful as a group-specific EIA antigen to diagnose diseases caused by members of the family Enterobacteriaceae.
members of the family Enterobacteriaceae have been shown to be closely related (4, 5, 7) . The N-terminal two-thirds of the 325-amino acid residue-long OmpA molecule of E. coli spans the outer membrane eight times, forming four short loops on the bacterial surface ( Fig. 1) (15, 23, 34) . These loops serve as receptors for several OmpA-specific bacteriophages (33) . The conformation of the protein as it is embedded in the outer membrane is believed to be important for its phage receptor function, since denatured OmpA does not bind these phages but gains phage-binding ability when complexed with lipopolysaccharide (LPS), a major component of the outer membrane (6) .
The C-terminal third of OmpA is hydrophilic and located in the periplasmic space ( Fig. 1) (15, 23, 34) . The C-terminal domain is not essential for the localization of OmpA in the outer membrane or for its function as phage receptor (5) .
Antibodies to OmpA are produced in response to immunization with isolated OmpA or with whole bacteria, as well as during infection caused by enteric bacteria (8, 25, 31 ; M. Karvonen, R. Puohiniemi, V. Valtonen, P. Ruutu, H. Arvilommi, M. Sarvas, and P. H. Makela, submitted for publication). Their epitope specificities have so far not been studied in detail. Theoretically, one would expect that the phage receptor loops on the bacterial surface would be important antigenic epitopes (14) . The membrane-spanning regions embedded in the lipid bilayer would not be likely to be exposed for binding of antibodies or stimulation of B * Corresponding author.
cells. The C-terminal domain located in the periplasmic space, on the other hand, could be expected to stimulate B cells for antibody production only after exposure by breakdown of the bacteria.
Anti-OmpA antibodies are cross-reactive between enterobacterial species (2, 10, 11) , suggesting that OmpA might be useful as an antigen for diagnostic tests. For this purpose, it is necessary to have an easy method of preparing OmpA in large quantities and free of other outer membrane components. We considered production of OmpA in the grampositive bacterium Bacillus subtilis to be a promising method for this purpose. The same approach could also provide a tool for studying the antigenic properties of different parts of the OmpA. We cloned two forms of the ompA gene of E. coli into B. subtilis, one coding for the full-length mature OmpA (this study) and the other coding for the N-terminal twothirds of the protein (13 (23) with permission of the publisher. (19) , and B. subtilis was grown in twofold-concentrated L-broth containing 10 mg of NaCl per liter, 10 ,ug of kanamycin per ml, and 30 ,ul of potato extract per ml (12) .
Recombinant DNA techniques. The recombinant DNA techniques used were essentially those of Maniatis et al. (21) .
Gel electrophoresis. Proteins were electrophoresed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) with 12% acrylamide (17, 30) and then either stained with Coomassie brilliant blue or immunoblotted with rabbit anti-OmpA antiserum (Table 2 ) by using peroxidaseconjugated anti-rabbit immunoglobulin G (Bio-Rad Laboratories, Richmond, Calif.) as the second antibody (30) .
Isolation of Bac-OmpA. The method for extraction of Bac-OmpA from B. subtilis was based on previous experience with the N-terminal fragment of OmpA containing amino acids 8 to 228 (13) . Strain IH6543, containing pKTH217, was grown to early stationary phase, i.e., 6 to 9 h after reaching the optical density of 100 Klett units (KlettSummerson photometer, red filter). The cells were protoplasted with lysozyme and then disrupted by osmotic shock and sonication. After removal of the unbroken cells and protoplasts by low-speed centrifugation (3,000 x g, 10 min, 4°C), the membranes and particulate material were pelleted by centrifugation at 30,000 x g for 60 min at 4°C (Fig. 2, lane  3) . Part of the membrane proteins was extracted from the pellet (the particulate fraction) with 5% Triton X-100 in 50 mM Tris-hydrochloride buffer (pH 8) in the presence of 50 mM EDTA (Fig. 2, lane 4) . Bac-OmpA was solubilized from the remaining pellet (Fig. 2 , lane 5) with 2% Sarkosyl in the buffer described above in the presence of 1 mM EDTA (Fig.  2, lane 6) , and the insoluble material (for instance, flagellin, 36 kilodaltons [kDa]) was removed by centrifugation (20, 000 x g, 20 min, 4C) (Fig. 2, lane 7) .
The Sarkosyl supernatant, which contained the bulk of the Bac-OmpA protein, was then dialyzed extensively against 2 mM NaHCO3. It still contained bacillar proteins (Fig. 2, Antigens. Bac-OmpA, OmpA protein produced in B. subtilis IH6543, was prepared as described above. Bac-OmpAdN was isolated from IH6443 in a similar manner. It consists of a truncated OmpA containing the N-terminal two-thirds of the protein as a tandem duplication. The duplication was used because of its higher yield of the protein; in preliminary experiments by the enzyme immunoassay (EIA) used in this study and by studying the phage receptor activity (unpublished data), this form has given results identical to those yielded by the nonduplicated form. Bac-Mock, the control antigen, was prepared in a similar manner from strain IH6418, which contains the expression vector without ompA. Coli-OmpA was purified by preparative SDS-PAGE (30) from E. coli K-12 (strain PL 2), and Salmonella-OmpA was prepared from S. typhimurium his-515 (26) . All antigens were stored at -70°C.
Hyperimmune sera. Table 2 shows the hyperimmune sera used. New Zealand White rabbits were immunized with 20 to 40 ,ug of protein in Freund complete adjuvant per injection. Three injections over a period of 6 weeks were given into the popliteal lymph nodes, and the rabbits were bled 10 days after the last injection (18) . (CBAxC57BI/6)F1 hybrid mice were immunized with live or heat-killed bacteria or with 10 ,ug of protein per injection, and sera from 10 mice were pooled (24) . All sera were stored at -20°C until use. ETA. The EIA was performed by the method of Voller et al. (35) , with some modifications. Flat-bottomed microdilution plates (Immunolon; Dynatech, London, United Kingdom) were coated with 100 ,ul of the antigen diluted in Tris hydrochloride buffer, pH 8.5, to a concentration of 5 jxg/ml. The plates were incubated overnight at 22°C and then washed three times with phosphate-buffered saline (PBS) containing 0.05% Tween and once with PBS alone. The sera to be assayed were diluted 1:100, 1:1,000, 1:10,000 (and further when necessary) in PBS containing 10% fetal calf serum (PBS-FCS) (Difco Laboratories, Detroit, Mich.). To each well, 100 ,u of each dilution was added. After 2 h of incubation at 37°C, the plates were washed as described above. Peroxidase-conjugated anti-rabbit immunoglobulin G or anti-mouse immunoglobulin (Dakopatts, Copenhagen, Denmark) was diluted in PBS-FCS, and 100 pAl was added to each well. The plates were incubated for 1 h at 22°C. After being washed as described above, 100 pd of the substrate, containing 0.4 mg of 1,2-phenylenediaminedihydrochloride (Fluka AG, Buchs, Switzerland), and 0.4 pul of 30% H202 in 1 ml of 0.1 M phosphate-citrate buffer at pH 5.5 were added to the wells. The reaction was stopped after 15 min at 22°C by adding H2SO4. The A492 was measured by using a Titertek Multiskan spectrophotometer (Labsystems, Helsinki, Finland), and the endpoint titer (16) was calculated at the cutoff value of 0.300.
RESULTS
Subcloning and expression of the ompA gene in B. subtilis. The ompA gene was subcloned in two steps into the plasmid pKTH132, which allows a good expression of many foreign proteins in B. subtilis (13, 29) , as shown in Fig. 3 BamHI site of pKTH215. The correct orientation of the inserted fragment in pKTH217 was confirmed by the presence of the expected fragments after digestion with HindIII and BglIl. The ompA gene of plasmid pKTH217 was expressed in B. subtilis (Fig. 2) in a manner similar to that of the N-terminal two-thirds of OmpA which was found in the particulate fraction with uncleaved signal peptide, as described earlier (13) . Thus, the size of the protein that reacted with anti-OmpA antiserum was approximately 38 kDa, indicating the presence of the signal sequence. The protein, Bac-OmpA, was found in the particulate fraction, from which it was solubilized as described in Materials and Methods and the legend to Fig. 2 .
Immunization with OmpA proteins. Rabbits were immunized with the three OmpA preparations: the full-length Coli-OmpA isolated from E. coli and the full-length BacOmpA and the N-terminal two-thirds of OmpA (Bac-OmpAdN) produced in B. subtilis. The results are shown for one rabbit in each category in Fig. 4 ; the other sera gave similar results. Before immunization (normal rabbit serum), no anti-OmpA antibodies were detectable. Both full-length preparations elicited a high titer of antibodies (>106) detected by EIA with either Coli-OmpA or Bac-OmpA as the antigen (Fig. 4) . These two OmpA preparations were equally good antigens in the EIA. In contrast, the antibody titers of both hyperimmune sera were 1,000-fold less when the Nterminal Bac-OmpA-dN was used as the EIA antigen, demonstrating that the main antibody response to purified OmpA was directed to the C-terminal part of the protein.
Immunization of rabbits with the N-terminal Bac-OmpAdN yielded an antibody titer 1,000-fold lower (104) than those obtained by immunizing rabbits with Coli-OmpA or BacOmpA (compare serum KH722 to the sera KH591 and KH1018 in Fig. 4 ). As expected, the titer of serum KH722 was practically the same with any of the three OmpA preparations as the antigen. Thus, the N-terminal two-thirds of purified OmpA seems to be of poor immunogenicity.
Similar results were obtained when mice were immunized with isolated Salmonella-OmpA (serum HH53); a high titer (106) was found by EIA with the full-length Bac-OmpA antigens, and a much lower titer (102) was found with the N-terminal Bac-OmpA-dN. These data also confirm the high immunological cross-reactivity between the OmpA proteins of E. coli and S. typhimurium (7) .
Immunization with whole bacteria. E. coli or S. typhimurium cells (Fig. 4) . The heat-killed bacteria elicited a high anti-OmpA antibody titer (104) when measured by EIA with Bac-OmpA and elicited a 100-foldlower titer (102) when measured with the N-terminal BacOmpA-dN. The OmpA was thus a good immunogen even in intact bacteria, and again a strong antibody response was directed to its C-terminal part-a remarkable finding considering the periplasmic location of the C terminus.
In further experiments, we examined the antibody response to OmpA in live bacteria. Ten mice were injected intraperitoneally with a sublethal dose of live E. coli 018:K1 that produces peritonitis and septicemia (36, 37) . They recovered in a few days; the serum was collected 3 weeks later and pooled (serum HH1). Another group of 10 mice was injected with 106 cells of a nonvirulent aroA mutant of S. typhimurium (12) ; the bacteria survived in the liver and spleen of the animals for approximately 2 weeks (24). The serum, HH8, was collected 3 weeks after infection. The antibody titers were high (104) in both sera when Bac-OmpA was used as the EIA antigen, and again they were 100-fold lower with the N-terminal Bac-OmpA-dN antigen. Serum from uninfected mice did not react with either antigen (Fig.  4) , and the control antigen Bac-Mock did not react with either serum (titer less than 100; data not shown). Thus, there was a substantial immune response to OmpA during infection, and much of it was again directed to the C-terminal part of the molecule. Furthermore (9) have provided data pertinent to this question. They isolated a number of monoclonal antibodies after immunization of mice with whole formalinized bacteria. All 10 antibodies that reacted with an outer membrane preparation also reacted in Western blots, suggesting that the main antigenic epitopes were linear. Furthermore, the five OmpA-specific antibodies did not bind to intact bacteria as tested by bacterial agglutination, EIA, and fluorescent-antibody binding. These data thus confirm and extend our findings suggesting that the antibody response to OmpA, either in the denatured form or as part of intact bacteria, is directed to the C-terminal domain of the protein.
The C-terminal part of OmpA is highly conserved in the enteric bacteria (3, 4, 7) ; since it is the epitope efficiently recognized by antibodies formed during infection, it could be expected to be an ideal, broadly cross-reactive antigen to be used in immunodiagnosis of diseases caused by enteric bacteria. We have actually shown that Bac-OmpA can be used to diagnose both E. coli and Salmonella infections in humans (Karvonen et al., submitted); the data of Henriksen et al. (9) suggest that anti-OmpA antibodies are broadly cross-reactive within the family Enterobacteriaceae but not outside it. On the other hand, the immunodominance of the C-terminal domain means that anti-OmpA antibodies would not be expected to be protective since their target is not exposed on the bacterial surface. This is consistent with the inability of anti-OmpA antibodies to protect against experimental E. coli and Salmonella infections (37) , although the presence of smooth LPS and capsule in the infective bacteria could have led to the same result. Actually, it is tempting to speculate that the lack of accessibility to possibly protective antibodies may have been an important factor in allowing the C-terminal part of OmpA to remain so conserved.
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